Physician

Michael Marc Wolz, MBCHB

According to 2025 Medicare claims, Michael Wolz, MBCHB (NPI: 1689986291) practices dermatology in the Duluth, MN-WI market, with the plurality of this provider's patient population coming from St. Louis, MN. This provider's primary affiliated billing organization is THE DULUTH CLINIC, LTD (NPI: 1245278209; TIN: 410883623) and primary practice location at 55805-1951. Wolz is affiliated with the Essentia Health ACO, Inc. (ACO ID: A5617), participating under the MSSP model.

Wolz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 491 traditional Medicare patients, billed 3,840 HCPCS/CPT codes, and received $190,187 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 420 prescription claims across 262 beneficiaries totaling $15,321 in drug costs, led by Fluorouracil (Fluorouracil). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $48,836 to $15,321. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$119K$237K2015 Medicare payment: $151,969 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $182,173 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $177,023 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $184,246 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $206,847 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $218,329 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $237,036 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $223,109 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $193,820 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $190,187 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153702,355$151,969
20164033,412$182,173
20174473,833$177,023
20184263,927$184,246
20194523,948$206,847
20204713,760$218,329
20215624,697$237,036
20225414,544$223,109
20234963,816$193,820
20244913,840$190,187

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$32K$65K2015 Drug cost: $48,836 (USD; Tot_Drug_Cst)2016 Drug cost: $64,670 (USD; Tot_Drug_Cst)2017 Drug cost: $64,882 (USD; Tot_Drug_Cst)2018 Drug cost: $42,977 (USD; Tot_Drug_Cst)2019 Drug cost: $48,912 (USD; Tot_Drug_Cst)2020 Drug cost: $27,943 (USD; Tot_Drug_Cst)2021 Drug cost: $21,668 (USD; Tot_Drug_Cst)2022 Drug cost: $53,726 (USD; Tot_Drug_Cst)2023 Drug cost: $20,138 (USD; Tot_Drug_Cst)2024 Drug cost: $15,321 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015177400$48,836
2016161370$64,670
2017214406$64,882
2018213395$42,977
2019213380$48,912
2020193309$27,943
2021305500$21,668
2022257454$53,726
2023275443$20,138
2024262420$15,321

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks233298$219
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more169191$44
17000Destruction of precancer skin growth, 1 growth255287$35
11102Biopsy of related skin growth, first growth191227$14
17003Destruction of precancer skin growth, 2-14 growths2331,755$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil732,172$4,824
MetronidazoleMetronidazole501,550$2,858
Clobetasol PropionateClobetasol Propionate20753$1,903
KetoconazoleKetoconazole952,977$1,678
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc23898$623

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Michael Marc Wolz, MBCHB?

Tedicare shows public-source Medicare data for Michael Marc Wolz, MBCHB (NPI 1689986291), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Marc Wolz, MBCHB have ACO affiliation data?

Michael Marc Wolz, MBCHB is shown with ACO affiliation data for Essentia Health ACO, Inc. (MSSP, ACO ID A5617).

What billing organization is linked to Michael Marc Wolz, MBCHB?

Michael Marc Wolz, MBCHB is linked to THE DULUTH CLINIC, LTD (billing NPI 1245278209) in the available physician profile data.

Does Michael Marc Wolz, MBCHB have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.